What is Moolec Science SA Ordinary Shares?
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally.
MLEC · Verdict
Moderate reward · high risk
MLEC's standout is volatility; balance sheet and profitability weigh on the picture.
Based on 88% data coverage
MLEC · Verdict
Above average
Current ratio 0.13
-33% net margin · -175% ROE
-9% free-cash-flow margin
Model-based scoring. For information only — not financial advice.
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 11.71M.
The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.